Cargando…
Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647852/ https://www.ncbi.nlm.nih.gov/pubmed/36270792 http://dx.doi.org/10.1136/ejhpharm-2022-003416 |
_version_ | 1785135205159272448 |
---|---|
author | Thomas, Emma Tomlinson, Sam Thomas, Siwan Ward, Suzanne Daugherty, Claire Gallardo, Eva Hill, Christon |
author_facet | Thomas, Emma Tomlinson, Sam Thomas, Siwan Ward, Suzanne Daugherty, Claire Gallardo, Eva Hill, Christon |
author_sort | Thomas, Emma |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10647852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-106478522022-10-21 Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study Thomas, Emma Tomlinson, Sam Thomas, Siwan Ward, Suzanne Daugherty, Claire Gallardo, Eva Hill, Christon Eur J Hosp Pharm PostScript BMJ Publishing Group 2023-11 2022-10-21 /pmc/articles/PMC10647852/ /pubmed/36270792 http://dx.doi.org/10.1136/ejhpharm-2022-003416 Text en © European Association of Hospital Pharmacists 2023. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | PostScript Thomas, Emma Tomlinson, Sam Thomas, Siwan Ward, Suzanne Daugherty, Claire Gallardo, Eva Hill, Christon Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study |
title | Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study |
title_full | Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study |
title_fullStr | Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study |
title_full_unstemmed | Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study |
title_short | Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study |
title_sort | treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational uk patient registry study |
topic | PostScript |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647852/ https://www.ncbi.nlm.nih.gov/pubmed/36270792 http://dx.doi.org/10.1136/ejhpharm-2022-003416 |
work_keys_str_mv | AT thomasemma treatmentoflifethreateningdigoxintoxicitywithdigoxinspecificantibodyfragmentsresultsfromaprospectivenoninterventionalobservationalukpatientregistrystudy AT tomlinsonsam treatmentoflifethreateningdigoxintoxicitywithdigoxinspecificantibodyfragmentsresultsfromaprospectivenoninterventionalobservationalukpatientregistrystudy AT thomassiwan treatmentoflifethreateningdigoxintoxicitywithdigoxinspecificantibodyfragmentsresultsfromaprospectivenoninterventionalobservationalukpatientregistrystudy AT wardsuzanne treatmentoflifethreateningdigoxintoxicitywithdigoxinspecificantibodyfragmentsresultsfromaprospectivenoninterventionalobservationalukpatientregistrystudy AT daughertyclaire treatmentoflifethreateningdigoxintoxicitywithdigoxinspecificantibodyfragmentsresultsfromaprospectivenoninterventionalobservationalukpatientregistrystudy AT gallardoeva treatmentoflifethreateningdigoxintoxicitywithdigoxinspecificantibodyfragmentsresultsfromaprospectivenoninterventionalobservationalukpatientregistrystudy AT hillchriston treatmentoflifethreateningdigoxintoxicitywithdigoxinspecificantibodyfragmentsresultsfromaprospectivenoninterventionalobservationalukpatientregistrystudy |